Interleukin-34 Level in Periodontal Disease
Periodontal Disease Stage 2
About this trial
This is an interventional treatment trial for Periodontal Disease Stage 2
Eligibility Criteria
Inclusion Criteria: Patients with stage II Periodontitis. Both genders aged from 20-50 years Minimum 20 natural teeth excluding third molars Good compliance with the plaque control instructions following initial therapy. Availability for follow-up and maintenance program. Exclusion Criteria: .•Smokers Pregnant and lactating females. Systemic diseases that could affect the outcome of the therapy (According to Cornell Medical Index-Health Questionnaire). Patients taking antibiotics, anti-inflammatory, and immunosuppressive therapy during the preceding 3 months before the start of the trial and during the study. Patients who have undergone any periodontal therapy in the last 6 months Vulnerable groups of patients e.g. (handicapped patients).
Sites / Locations
- Faculty of Dentistry-Ain Shams UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
No Intervention
Active Comparator
Healthy individuals
Stage II periodontitis patients
No intervention
Non-surgical periodontal therapy by ultrasonic and universal curettes